Tradestie Institutional Equity Comparison Engine

BBIO vs BHVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BHVN Overall Edge

BHVN Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biohaven Ltd. (BHVN) driven by superior Growth & Margin, Momentum & Technical while BBIO counters with relative strength in Options & Structure. Fundamentally, BBIO trades at N/M Forward P/E with -37.3% operating margin (+192.6% YoY revenue) versus BHVN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, BBIO sits in CONSOLIDATION (3rd %ile IV; Dealer Gamma Walls on Pro) against BHVN sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BBIO N/M vs BHVN N/M Fwd P/E
Growth & Margin Winner BHVN
Op Margin -37.3% vs 0.0% ยท YoY +192.6% vs +0.0%
Momentum & Technical Winner BHVN
1Y +19.3% vs +72.6% ยท 52W Pos 49% vs 59%
Options & Structure Winner BBIO
CONSOLIDATION (3rd %ile IV) vs CONSOLIDATION (18th %ile IV)
BBIO NASDAQ
BridgeBio Pharma, Inc. Common Stock
Pharmaceutical Preparations
$77.61
-0.89% 1D
Market Cap $15.2B
1M Return +16.89%
1Y Return +19.28%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 19.0 Fund 40.0 Flow 66.0 Mom 40.0
BHVN NYSE
Biohaven Ltd.
Pharmaceutical Preparations
$13.95
+0.9% 1D
Market Cap $2.1B
1M Return +29.36%
1Y Return +72.59%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 15.0 Fund 42.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BBIO +19.28% BHVN +72.59% Spread: +53.31 pp (BHVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BBIO TTM Op. Margin: -37.3% BHVN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BBIO vs BHVN. Trailing 12-month operating profitability (BBIO -37.3% vs BHVN 0.0%) and valuation multiples (BBIO N/M vs BHVN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BBIO (4) vs BHVN (4)
Institutional Metric BBIO BHVN Criterion Row Winner
Market Capitalization Scale $15.2B $2.1B Larger Scale BBIO
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +192.6% +0.0% Higher Growth BBIO
Operating Margin (TTM) Profitability -37.3% 0.0% Higher Margin BHVN
Net Profit Margin Profitability -59.8% 0.0% Higher Margin BHVN
Return on Equity (ROE) Capital Efficiency -1789.7% -799.5% Higher ROE BHVN
52-Week Range Position Momentum 49% ($62โ€“$93) 59% ($8โ€“$18) Stronger Trend BHVN
Beta / 30D Volatility Risk Regime 0.87ฮฒ ยท 38% Vol 1.40ฮฒ ยท 111% Vol Lower Realized Risk BBIO
Unified Institutional Score Composite Signal 44.5 / 100 (HOLD) 42.1 / 100 (HOLD) Higher Composite BBIO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BBIO vs BHVN Buy Guide
BBIO CONSOLIDATION
91d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live BBIO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BHVN CONSOLIDATION
91d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live BHVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BBIO nor BHVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.